BioSpace News Archive

Policy

CPHO Sunday Edition: Vaccine safety in Canada: What you should know

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

March 28, 2021
·
8 min read
Drug Development

Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint

Shanghai Henlius Biotech, Inc. announced that the Phase 2 study of its innovative PD-1 inhibitor HLX10 in patients with unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors that fail to respond to the standard therapy has met the primary endpoint.

March 28, 2021
·
6 min read
Policy

Mezzion Announces Re-Submission of New Drug Application for its Orphan Drug Udenafil to Treat Patients who have undergone the Fontan Operation for Single Ventricle Heart Disease

Mezzion Pharma Co. Ltd., announced that it has re-submitted a New Drug Application to the U.S. Food and Drug Administration for the approval of udenafil to improve the exercise capacity of patients 12 years of age and older with single ventricle heart disease who have undergone the Fontan operation.

March 28, 2021
·
7 min read
Business

Nordic Nanovector ASA publishes 2020 Annual Report

On 26 March 2021, the Board of Directors of Nordic Nanovector ASA approved the Company’s financial statements for 2020.

March 28, 2021
·
1 min read
Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research

Core One Labs Inc. is pleased to announce that its wholly owned subsidiary Rejuva Mental Health Clinic has retained Dr. Stephen Peach as Lead Physician.

March 28, 2021
·
5 min read